Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A (1995) Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 137-141

Baldwin D, Mayers A (2003) Sexual side-effects of antidepressant and antipsychotic drugs 9:202-210. http://apt.rcpsych.org/

Begley CM, Higgins A (2006) Iatrogenic sexual dysfunction and withholding of information iatrogenic sexual dysfunction and the protective withholding of information: in whose best interest? J Psychiatr Mental Health Nurs 13:437–446

Bobes J, García-Portilla MP, Rejas J, Hernández G, Garcia-Garcia M, Rico-Villademoros F, Porras A (2003) Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 29:125–147. https://doi.org/10.1080/713847170

Boer MKD, Castelein S, Wiersma D, Schoevers RA, Knegtering H (2015) The facts about sexual (dys)function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull 41:674–686. https://doi.org/10.1093/schbul/sbv001

Boora K, Chiappone K, Dubovsky S, Xu J (2010) Ziprasidone-induced spontaneous orgasm. J Psychopharmacol 24:947–948. https://doi.org/10.1177/0269881108100321

Bostwick JR, Guthrie SK, Ellingrod VL (2009) Antipsychotic-induced hyperprolactinemia (vol 29)

Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS (2004) Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients. Psychopharmacol 175:367–373. https://doi.org/10.1007/s00213-004-1826-6

Cheng Y, Chen Y, Zhao X, Mou F, Wang W, Yu Qian R, S, (2024) The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Front Pharmacol 15. https://doi.org/10.3389/fphar.2024.1423075

Dervaux A, Omari FE (2005) Sexual dysfunction in schizophrenics patients, the role of antipsychotics. Press Med 34:529–532. https://doi.org/10.1016/s0755-4982(05)83966-1

Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde eV (2019)S3-leitlinie schizophrenie 91(46). https://www.awmf.org/leitlinien/detail/ll/038-009.html

Fleischhacker WW, Uchida H (2014) Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int J Neuropsychopharmacol 17:1083–1093. https://doi.org/10.1017/S1461145712000399

Fujii A, Yasui-Furukori N, Sugawara N, Sato Y, Nakagami T, Saito M, Kaneko S (2010) Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuro-Psychopharmacol Biol Psychiatry 34:288–293. https://doi.org/10.1016/j.pnpbp.2009.11.022

Fujioi J, Iwamoto K, Banno M, Kikuchi T, Aleksic B, Ozaki N (2017) Effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. Pharmacopsychiatry 50:74–78. https://doi.org/10.1055/s-0042-116323

Haddad PM, Wieck A (2004) Antipsychotic-induced hyperprolactinaemia mechanisms, clinical features and management. Drugs 64:2291–2314. https://doi.org/10.2165/00003495-200464200-00003

Hashimoto N et al (2023) Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project. BMC Psychiatry 23. https://doi.org/10.1186/s12888-023-04908-4

Hwang T, Shah T, Sadeghi-Nejad H (2021) A review of antipsychotics and priapism. Sex Med Rev 9:464–471. https://doi.org/10.1016/j.sxmr.2020.10.003

Just MJ (2015) The influence of atypical antipsychotic drugs on sexual function. Neuropsychiatr Dis Treat 11:1655–1661. https://doi.org/10.2147/NDT.S84528

Kennedy SH, Rizvi S (2009) Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 29:157–164. https://doi.org/10.1097/JCP.0b013e31819c76e9

Kikuchi T, Uchida H, Suzuki T, Watanabe K, Kashima H (2011) Patients’ attitudes toward side effects of antidepressants: an internet survey. Eur Arch Psychiatry Clin Neurosci 261:103–109. https://doi.org/10.1007/s00406-010-0124-z

Knegtering H, van den Bosch R, Castelein S, Bruggeman R, Sytema S, van Os J (2008) Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology 33:711–717. https://doi.org/10.1016/j.psyneuen.2008.02.008

Krüger TH, Hartmann U, Schedlowski M (2005) Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 23:130–138. https://doi.org/10.1007/s00345-004-0496-7

Lohse MJ, Seifert J, Bleich S (2021) Psychopharmaka.In Ludwig WD, Mühlbauer B, Seifert R (eds) Arzneiverordnungs-report 2021, pp 689–725. Berlin, Heidelberg: Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-63825-5_39

Maguire GA (2002) Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J clin psychiatry 63:56–62

Mahmoud A, Hayhurst KP, Drake RJ, Lewis SW (2011) Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trial. Schizophr Res Treat 2011:1–6. https://doi.org/10.1155/2011/596898

Melis MR, Sanna F, Argiolas A (2022) Dopamine, erectile function and male sexual behavior from the past to the present: a review. Brain Scie 12. https://doi.org/10.3390/brainsci12070826

Möller HJ (2005) Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? Eur Arch Psychiatry Clin Neurosci 255:190–201. https://doi.org/10.1007/s00406-005-0587-5

Peuskens J, Sienaert P, Hert MD (1998) Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry 13:23–30

Pöttgen J, Rose A, Vis WVD, Engelbrecht J, Pirard M, Lau S, Cerqueda C (2018) Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: a scoping review. PLoS ONE 13. https://doi.org/10.1371/journal.pone.0193381

Puijenbroek EPV, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC (2002) A comparison of measures of disproportionality for signal detection is spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11:3–10. https://doi.org/10.1002/pds.668

Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10:796–803. https://doi.org/10.7150/ijms.6048

Salata B, Kluczna A, Dzierżanowski T (2022) Opioid-induced sexual dysfunction in cancer patients. Cancers 14. https://doi.org/10.3390/cancers14164046

Serretti A, Chiesa A (2011) A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Neuropsychopharmacol 26:130–140. https://doi.org/10.1097/YIC.0b013e328341e434

Silva C, Rebelo M, Chendo I (2023) Managing antipsychotic-related sexual dysfunction in patients with schizophrenia. Expert Rev Neurother 23(12):1147–1155. https://doi.org/10.1080/14737175.2023.2281399

Souaiby L, Kazour F, Zoghbi M, Khalil RB, Richa S (2020) Sexual dysfunction in patients with schizophrenia and schizoaffective disorder and its association with adherence to antipsychotic medication. J Mental Health 29:623–630. https://doi.org/10.1080/09638237.2019.1581333

Su CC, Lai ECC, Yang YHK, Man KK, Kubota K, Setoguchi Stang P, S, (2020) Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: a cross-nation comparison with common data model. J Psychiatric Res 131:77–84. https://doi.org/10.1016/j.jpsychires.2020.08.025

Tharoor H, Kaliappan A, Gopal S (2015) Sexual dysfunctions in schizophrenia: professionals and patients perspectives. Indian J Psychiatry 57:85–87. https://doi.org/10.4103/0019-5545.148532

Torre AL, Conca A, Duffy D, Giupponi G, Pompili M, Grözinger M (2013) Sexual dysfunction related to psychotropic drugs: a critical review part II: Antipsychotics. Pharmacopsychiatry 46:201–208. https://doi.org/10.1055/s-0033-1347177

Traish A, Kim NN, Moreland RB, Goldstein I (2000) Role of alpha adrenergic receptors in erectile function. Int J Impot Res 12:48-63. www.nature.com/ijir